| Issue |
Title |
File |
| Vol 20, No 3 (2018) |
Differential diagnosis of lung cancer and tuberculosis: review |
(Rus)
|
|
Belova O.S., Komarov I.G.
|
| Vol 22, No 4 (2020) |
Differentiated thyroid cancer |
(Rus)
|
|
Bel’tsevich D.G., Mudunov A.M., Vanushko V.E., Rumiantsev P.O., Mel’nichenko G.A., Kuznetsov N.S., Podvyaznikov S.O., Alymov Y.V., Poliakov A.P., Fadeev V.V., Bolotin M.V., Sevriukov F.E., Krylov V.V., Fedenko A.A., Bolotina L.V., Zharov A.A., Falaleeva N.A., Filonenko E.V., Nevol’skikh A.A., Ivanov S.A., Khailova Z.V., Gevorkian T.G.
|
| Vol 16, No 2 (2014) |
Difficulties in treating patients with breast cancer in Russia: the resolution on the results of the Review Board |
|
|
Artamonova E.V., Gorbunova V.A., Zhukov N.V., Manzjuk L.V., Manihas A.G., Paltuev P.M., Semiglazov V.F., Semiglazova T.Y., Stenina M.B., Tjuljandin S.A., Chubenko V.A.
|
| Vol 18, No 5 (2016) |
Difficulties of diagnosing of the Langerhans histiocytosis |
|
|
Shatokhin Y.V., Snezhko I.V., Kuzub E.I., Shatokhina O.N., Matsionis A.E., Pavilaytite P.E., Nagornaya G.Y., Gerasimova O.V., Burnasheva E.V., Ryabikina E.V.
|
| Vol 25, No 3 (2023) |
Diffuse large B-cell lymphoma: strokes to the epidemiological portrait. A review |
(Rus)
|
|
Poddubnaya I.V., Babicheva L.G., Bariakh E.A.
|
| Vol 24, No 4 (2022) |
Disability-Adjusted Life Year (DALY) assessment and economic damage from premature death of cervical uterine and ovarian cancers in the Tomsk Region |
(Rus)
|
|
Zhuikova L.D., Ananina O.A., Sirotina A.S., Pikalova L.V., Fokin V.A., Kononova G.A.
|
| Vol 23, No 4 (2021) |
Disseminated Kaposi sarcoma with osseous metastases in patients with HIV infection. Case report |
(Rus)
|
|
Ognerubov N.A., Antipova T.S.
|
| Vol 11, No 1 (2009) |
Dlitel'noe i bezopasnoe primenenie Avastina pri metastaticheskom kolorektal'nom rake: klinicheskiy opyt primeneniya |
|
|
Zhukova L.G.
|
| Vol 14, No 1 (2012) |
Dlitel'nyy effekt kombinirovannogolecheniya metastaticheskogo rakazheludka (klinicheskiy sluchay) |
|
|
Khvastunov R.A., Ivanov A.I.
|
| Vol 12, No 3 (2010) |
Dobavlenie Zomety (zoledronata)k ad\"yuvantnoy endokrinoterapiiuvelichivaet vyzhivaemost' bol'nykhrannim retseptor-pozitivnym rakommolochnoy zhelezy |
|
|
Zhukov N.V.
|
| Vol 23, No 1 (2021) |
Don’t let it disappear: new opportunities to prolong the life of HR+ HER2- advanced breast cancer patients. Event review of the satellite symposium. RUSSCO Big Conference «Breast Cancer» (online). January 28th, 2021 |
(Rus)
|
|
Board E.
|
| Vol 8, No 1 (2006) |
Dopolnitel'nye kliniko-laboratornye faktory prognoza pri diffuznoy krupnokletochnoy V-kletochnoy limfome |
|
|
Babicheva L.G., Poddubnaya I.V.
|
| Vol 5, No 2 (2003) |
Dostizheniya sovremennoy khimioterapii |
|
|
Poddubnaya I.V.
|
| Vol 14, No 1 (2012) |
Dotsetaksel v ad\"yuvantnoy terapiirannego raka molochnoy zhelezy bezporazheniya limfaticheskikh uzlov (N0) |
|
|
Artamonova E.V.
|
| Vol 23, No 3 (2021) |
Dual immunological blockade in the treatment of metastatic non-small cell lung cancer: reality and perspectives |
(Rus)
|
|
Yudin D.I., Laktionov K.K., Laktionova L.V., Breder V.V.
|
| Vol 18, No 2 (2016) |
Dural non-Hodgkin’s lymphomas |
(Rus)
|
|
Babicheva L.G., Baikov V.V., Leenman E.E., Vinogradova Y.N., Ilyin N.V., Ryabchikova V.V., Poddubnaya I.V.
|
| Vol 21, No 3 (2019) |
Durvalumab in the treatment of locally advanced non-small cell lung cancer after chemoradiotherapy in a real practice |
(Rus)
|
|
Sakaeva D.D., Ruchkin V.V., Goncharova O.V., Abbasova R.R., Mufazalov F.F.
|
| Vol 19, No 3 (2017) |
Dynamics of circulating tumor cells during neoadjuvant chemotherapy in patients with locally-advanced breast cancer |
(Rus)
|
|
Nenakhova Y.N., Lyadov V.K., Poddubnaya I.V.
|
| Vol 14, No 2 (2012) |
Dzhevtana® (kabazitaksel) - novyy preparat dlya lecheniya metastaticheskogo gormonorezistentnogo raka predstatel'noy zhelezy zaregistrirovan v Rossii |
|
|
- -.
|
| Vol 26, No 1 (2024) |
EDP chemotherapy combined with somatostatin analogues and mitotane in the treatment of disseminated adrenocortical carcinoma: a clinical case |
(Rus)
|
|
Magamedova O.R., Oganesyan L.V., Feoktistova P.S., Feidorov I.Y.
|
| Vol 21, No 3 (2019) |
Effect of starting dose of regorafenib on overall survival of patients with metastatic colorectal cancer: a systematic review and meta-analysis |
(Rus)
|
|
Fedyanin M.Y., Polyanskaya E.M., Tryakin A.A., Pokataev I.A., Tjulandin S.A.
|
| Vol 25, No 1 (2023) |
Effect of transfused donor and autoerythrocytes on the oncological outcomes of surgical treatment in patients with renal cell carcinoma with tumor-related venous thrombosis: observational study |
(Rus)
|
|
Volkova M.I., Feoktistov P.I., Begaliev A.K., Shin A.R., Matveev V.B., Prikhodchenko A.O.
|
| Vol 25, No 1 (2023) |
Effective prevention of COVID-19 infection in cancer patients receiving antitumor drug therapy: a regional analysis |
(Rus)
|
|
Valiachmetova C.K., Siraev E.R., Izmailov A.A.
|
| Vol 21, No 2 (2019) |
Effective use of the endoscopic vacuum system in the comprehensive treatment of a patient with a defect in the abdominal segment of the esophagus after gastrectomy |
(Rus)
|
|
Abu-Khaidar O.B., Vodoleev A.S., Pirogov S.S., Khomiakov V.M., Riabov A.B.
|
| Vol 25, No 4 (2023) |
Effectiveness and safety of empegfilgrastim (Extimia®, BIOCAD) in patients with lymphoproliferative diseases receiving cytotoxic therapy: results of LEGERITY, a multicenter retrospective-and-prospective observational post-marketing study |
(Rus)
|
|
Nesterova E.S., Saydullaeva A.F., Sherstnev D.G., Shelekhova T.V., Klitochenko T.Y., Khusainova G.N., Lysenko I.B., Lyalina I.S., Demchenkova M.V., Orlova S.A., Proydakov A.V., Betrozova М.V., Fadeeva N.V., Gofman A.A., Marchenko Y.M., Voloshin S.V., Pashneva E.A., Sarzhevskiy V.O., Babicheva A.R., Bondareva I.B., Glonina N.N., Ishchanov D.G., Poddubnaya I.V.
|
| Vol 24, No 1 (2022) |
Effectiveness and safety of empegfilgrastim (Extimia®, BIOCAD) in patients with lymphoproliferative diseases who receive cytotoxic therapy: results of LEGERITY, the second interim analysis of multicenter retrospective-and-prospective observational post-marketing study |
(Rus)
|
|
Nesterova E.S., Saydullaeva A.F., Sherstnev D.G., Shelekhova T.V., Klitochenko T.Y., Khusainova G.N., Lysenko I.B., Lyalina I.S., Demchenkova M.V., Orlova S.A., Proydakov A.V., Betrozova M.V., Fadeeva N.V., Gofman A.A., Marchenko Y.M., Voloshin S.V., Pashneva E.A., Sarzhevskiy V.O., Ishchanov D.G., Poddubnaya I.V.
|
| Vol 10, No 1 (2008) |
Effektivnost' ad\"yuvantnoy terapii anastrozolom i tamoksifenom u patsientok s rannimi stadiyami raka molochnoy zhelezy (analiz dannykh issledovaniya ATAC pri mediane vremeni nablyudeniya 100 mes) |
|
|
- -.
|
| Vol 3, No 2 (2001) |
Effektivnost' lecheniya tsiklosporinom A bol'nykh mielodisplasticheskimi sindromami v zavisimosti ot formy zabolevaniya |
|
|
Savchenko V.G., Parovichnikova E.N., Kokhno A.V., Mikhaylova E.A., Ol'shanskaya Y.V., Kaplanskaya I.B.
|
| Vol 4, No 3 (2002) |
Effektivnost' lingval'noy formy zofrana pri polikhimioterapii v onkopediatrii |
|
|
Kochurova N.V., Kuleva S.A., Kolygin B.A.
|
| Vol 11, No 1 (2009) |
Effektivnost' Taksoterav neoad\"yuvantnoy i ad\"yuvantnoy khimioterapii raka molochnoy zhelezy (Po materialam mezhdunarodnykh issledovaniy) |
|
|
Makarenko N.P., Poddubnaya I.V.
|
| Vol 12, No 2 (2010) |
Effektivnost' zatrat na ingibitorytirozinkinazy pri khronicheskomPh-pozitivnom mieloleykoze,rezistentnom k imatinibu |
|
|
Rudakova A.V.
|
| Vol 13, No 2 (2011) |
Effektivnost' zatrat nabendamustin v terapii indolentnykhnekhodzhkinskikh limfom |
|
|
Rudakova A.V., Poddubnaya I.V., Zaritskiy A.Y., Stadnik E.A.
|
| Vol 13, No 3 (2011) |
Effektivnost' zatrat nabendamustin v terapii khronicheskogolimfotsitarnogo leykoza |
|
|
Rudakova A.V.
|
| Vol 26, No 1 (2024) |
Efficacy and safety of alpelisib in patients with HR+HER2-negative metastatic breast cancer in real clinical practice: Results of a single-center observational retrospective study |
(Rus)
|
|
Sultanbaev A.V., Kolyadina I.V., Menshikov K.V., Musin S.I., Nasretdinov A.F., Sultanbaeva N.I., Rakhimov R.R., Lipatov D.O., Menshikova I.A., Izmailov A.A., Lipatova E.E.
|
| Vol 21, No 1 (2019) |
Efficacy and safety of eribulin in HER2-negative metastatic breast cancer: the results of long-term experience in real clinical practice in Russia |
(Rus)
|
|
Gorbunova V.A., Kolyadina I.V., Kovalenko E.I., Manziuk L.V., Artamonova E.V., Zhukova L.G., Bolotina L.V., Semiglazova T.I., Manikhas A.G., Raevskaia N.A., Itkin I.M., Filonenko D.V., Zhilyaeva L.A., Gol'dberg V.E., Popova N.O., Ponomarenko D.M., Shikina V.E., Suslova I.R., Romanchuk O.V., Kozlov D.V., Rzaev A.S., Marfutov V.V., Andreiashkina I.I., Vladimirova L.I., Mitashok I.S., Tikhanovskaia N.M., Karabina E.V., Mukhametshina G.Z., Khasanova A.I., Safina S.Z., Shaidorov M.V., Morozov D.A., Prokof'eva E.P., Kramskaia L.V., Karandeeva T.V., Evstigneeva I.V., Ovchinnikova E.G., Klement'eva T.P., Khrupalo O.V., Tiuvinova E.V., Sherstnev V.M., Chernov I.S., Kolokolov D.D., Gaisina E.A., Levchenko N.V., Chubenko V.A., Povyshev A.I., Iudina I.V., Vorotilina L.V., Andreeva T.V., Tumanian G.S., Koziakov A.E., Gil'mutdinova L.A., Osipov M.A., Shatokhina A.S., Vazhenina A.A., Chichkanova A.S., Vladimirov V.I., Ivanov A.N., Belokhvostova A.S., Cherniakova E.M., Tul'china E.A., Maklashova S.A., Shkodenko O.N., Kostalanova I.V., Tarasova A.V., Kuz'mina E.S.
|
| Vol 17, No 2 (2015) |
Efficacy and safety of extimia® (empegfilgrastim): results of a double-blind controlled phase iii study in patients with diagnosis «breast cancer» receiving myelosuppressive chemotherapy |
|
|
Krivorotko P.V., Burdaeva O.N., Nechaeva M.N., Frolova M.A., Kopp M.V., Abrosimova A.A., Ivanov R.A.
|
| Vol 25, No 3 (2023) |
Efficacy and safety of nurulimab+prolgolimab with continued prolgolimab therapy compared to prolgolimab alone as first-line therapy in patients with unresectable or metastatic melanoma: final results of the phase II OBERTON clinical study |
(Rus)
|
|
Samoylenko I.V., Demidov L.V., Moiseenko F.V., Dvorkin M.V., Demidova S.A., Protsenko S.A., Stroyakovskiy D.L., Kozlov V.V., Odintsova S.V., Kirtbaya D.V., Tantsyrev D.A., Mochalova A.S., Orlova R.V., Mukhametshina G.Z., Fadeeva N.V., Fomin E.A., Chapko Y.S., Tarasova A.V., Ermakov N.B., Shemerovskiy A.K., Vaschenko V.A., Chistyakov V.M., Zinkina-Orikhan A.V., Lin'kova Y.N., Kryukov F.B., Sorokina I.V., Siliutina A.A.
|
| Vol 15, No 1 (2013) |
Efficacy and safety of pemetrexed maintenance therapy in advanced non-small-cell lung cancer: a review of phase III studies |
|
|
Kit O.I., Vladimirova L.Y., Sholokhova E.A.
|
| Vol 17, No 3 (2015) |
Efficacy of cisplatin-based combinations in chemoradiation therapy of cervical cancer |
|
|
Bazaeva I.Y., Gorbounova V.A., Kravets O.A., Khokhlova S.V., Romanova E.A.
|
| Vol 24, No 4 (2022) |
Efficacy of immunotherapy (Prolgolimab) and targeted therapy (Trametinib and Dabrafenib, Cobimetinib and Vemurafenib) in adult patients with metastatic or unresectable skin melanoma: matching-adjusted indirect comparison |
(Rus)
|
|
Sapozhnikov K.V., Sokolova V.D., Sableva N.A., Tolkacheva D.G.
|
| Vol 15, No 2 (2013) |
Efficiency of denosumab in giant cell tumor of the bone |
|
|
Semenov N.N.
|
| Vol 15, No 1 (2013) |
Efficiency of radiotherapy for cancer of the vermilion border of lower lip in terms of balance between quantitative and qualitative results |
|
|
Garbuzov M.I.
|
| Vol 4, No 4 (2002) |
Ekspressiya molekulyarno-biologicheskikh markerov i ikh prognosticheskaya znachimost' pri sinovial'noy sarkome |
|
|
Keshta R.A., Stepanova E.V.
|
| Vol 10, No 3 (2008) |
Ekstranodal'nye nekhodzhkinskie limfomy s porazheniem myagkikh tkaney |
|
|
Bykov D.A., Subortseva I.N., Ozdoeva T.K., Tupitsyn N.N., Tumyan G.S., Sorokin E.N., Kondrat'eva T.T., Kovrigina A.M., Poddubnaya I.V., Semenova A.A., Khakuy R.A., Osmanov D.S.
|
| Vol 3, No 1 (2001) |
Ekzemestan (aromazin) v sovremennoy endokrinoterapii bol'nykh rakom molochnoy zhelezy |
|
|
Lichinitser M.R.
|
| Vol 23, No 3 (2021) |
ELEVATE-RR – first head-to-head trial of acalabrutinib versus ibrutinib in previously treated high risk chronic lymphocytic leukemia |
(Rus)
|
|
Bialik T.E., Vorob'ev V.I., Ionin V.A., Ysebaert L., Kaplanov K.D., Mendeleeva L.P., Nikitin E.A., Ptushkin V.V., Samoilova O.S., Stadnik E.A.
|
| Vol 22, No 1 (2020) |
ELEVATE-TN Study. New data of acalabrutinib in first-line treatment of chronic lymphocytic leukemia. Resolution |
(Rus)
|
|
Poddubnaya I.V., Al-Radi L.S., Byalik T.E., Kaplanov K.D., Molostvova V.Z., Nikitin E.A., Pospelova T.I., Ptushkin V.V., Samoilova O.S., Stadnik E.A., Tumyan G.S.
|
| Vol 25, No 3 (2023) |
Endobronchial metastasis of melanoma: a clinical case |
(Rus)
|
|
Ognerubov N.A., Palkina E.E., Sayapin O.E., Ognerubova M.A.
|
| Vol 25, No 3 (2023) |
Endoscopic criteria for early differential diagnosis of gastritis-like form of primary non-Hodgkin's lymphomas and gastric cancer: A prospective study |
(Rus)
|
|
Lozovaia V.V., Malikhova O.A., Tumanyan A.O., Gusarova O.A.
|
| Vol 23, No 4 (2021) |
Endoscopic esophageal stenting in combination with chemoradiation therapy: A review |
(Rus)
|
|
Ivanov A.I., Popov V.A., Burmistrov M.V.
|
| Vol 23, No 1 (2021) |
Endoscopic semiotics of metastatic bronchial tumors |
(Rus)
|
|
Kontsevaya A.Y., Krylovetskaia M.A., Malikhova O.A., Komarov I.G.
|
| Vol 2, No 3 (2000) |
Endoskopicheskaya diagnostika ekstranodal'noy limfosarkomy u detey |
|
|
Gubin A.N., Poddubnyy B.K., Kuvshinov Y.P., Nechipay A.M., Belousova N.V., Arkhipov V.V., Kiselev A.V., Ordukhanyan Z.S., Peterson I.S.
|
| Vol 7, No 3 (2005) |
Endoskopicheskaya diagnostika i lazernaya destruktsiya raka gortani |
|
|
Ungiadze G.V., Poddubnyy B.K., Belousova N.V., Kontsevaya A.Y.
|
| Vol 2, No 3 (2000) |
Endoskopicheskaya khirurgiya opukholevykh i posleoperatsionnykh stenozov u bol'nykh rakom pishchevoda i zheludka |
|
|
Kuvshinov Y.P., Poddubnyy B.K., Efimov O.N., Stilidi I.S., Smirnov O.M., Malikhova O.A., Gannenko I.P.
|
| Vol 7, No 3 (2005) |
Endoskopicheskaya retrogradnaya pankreatokholangiografiya v differentsial'noy diagnostike opukholey podzheludochnoy zhelezy |
|
|
Kuvshinov Y.P., Poddubnyy B.K., Kormnov V.G., Pirogov S.S.
|
| Vol 7, No 3 (2005) |
Endoskopicheskaya semiotika i diagnostika limfom glotochnogo kol'tsa Pirogova-Val'deyera |
|
|
Belousova N.V., Poddubnyy B.K., Ungiadze G.V., Arkhipov V.V., Gubin A.N.
|
| Vol 11, No 2 (2009) |
Epidemiologiya gastrointestinal'nykh stromal'nykh opukholey. Registr v Rossii: pervyy opyt |
|
|
Nikulin M.P., Stilidi I.S.
|
| Vol 14, No 4 (2012) |
Epidemiologiya kolorektal'nogo raka v Krasnodarskom krae |
|
|
Potemin S.N., Kazantseva M.V., Elizbaryan K.S., Davidenko I.S., Davidenko O.V.
|
| Vol 23, No 4 (2021) |
Epidemiology and status of specialized medical care for patients with cutaneous T-cell lymphomas: A survey of 163 patients of Russian Federation |
(Rus)
|
|
Kubanov A.A., Karamova A.E., Bogdanova E.V., Znamenskaya L.F., Vorontsova A.A.
|
| Vol 6, No 1 (2004) |
Epirubitsin (Farmorubitsin ) v ad\"yuvantnoy khimioterapii raka molochnoy zhelezy |
|
|
Stenina M.B.
|
| Vol 20, No 1 (2018) |
Epstein-Barr virus in children with classical Hodgkin’s lymphoma |
(Rus)
|
|
Botezatu I.V., Valiev T.T., Dushenkina T.E., Smirnova K.V., Ravshanova R.S., Maksimovich D.M., Likhtenstein A.V., Gurtsevich V.E., Popa A.V., Senyuta N.B.
|
| Vol 9, No 4 (2007) |
Erbituks – ratsional'no sozdannyy preparat dlya lecheniya zlokachestvennykh opukholey |
|
|
Garin A.M., Bazin I.S., Nasyrova R.Y.
|
| Vol 19, No 3 (2017) |
Eribulin for the treatment of anthracyclineand taxane-resistant breast cancer: a big step forward towards problem solving |
(Rus)
|
|
Artamonova E.V.
|
| Vol 11, No 4 (2009) |
Eritropoetiny v onkologii:pokazaniya k primeneniyu i problemy |
|
|
Besova N.S.
|
| Vol 23, No 2 (2021) |
Erythropoietin as an adjuvant treatment with (chemo) radiation therapy for head and neck cancer (Russian Translation of Cochrane Plain Language Summary – PLS) |
(Rus)
|
|
Alexandrova E.G.
|
| Vol 23, No 2 (2021) |
Erythropoietin or darbepoetin for patients with cancer (Russian Translation of Cochrane Plain Language Summary – PLS) |
(Rus)
|
|
Lienhard D.A.
|
| Vol 25, No 3 (2023) |
Esophageal anastomosis: experience of open surgery and modern possibilities of video endoscopic technologies. A review |
(Rus)
|
|
Nered S.N.
|
| Vol 7, No 2 (2005) |
Estramustina fosfat (estratsit) v lechenii raka predstatel'noy zhelezy (po materialam Journal of Clinical Oncology, 2005 ASCO Proceedings) |
|
|
Podregul'skiy K.E.
|
| Vol 25, No 4 (2023) |
Evaluation of follow-up strategies for women with epithelial ovarian cancer following completion of primary treatment [Russian translation of the Plain Language Summary (PLS) of the Cochrane Systematic Review] |
(Rus)
|
|
Yudina E.V.
|
| Vol 14, No 4 (2012) |
Everolimus: novye perspektivy terapii gormonopozitivnogo raka molochnoy zhelezy |
|
|
Kolyadina I.V., Makarenko N.P., Poddubnaya I.V.
|
| Vol 14, No 1 (2012) |
Evolyutsiya ad\"yuvantnoy lekarstvennoyterapii «rannego» raka molochnoyzhelezy (mnogotsentrovoeissledovanie) |
|
|
Kolyadina I.V., Poddubnaya I.V., Frank G.A., Komov D.V., Karseladze A.I., Ermilova V.D., Vishnevskaya Y.V., Makarenko N.P., Teterin K.A., Banov S.M., Guzieva Z.M.
|
| Vol 25, No 3 (2023) |
Experience in organizing nutritional support in cancer patients at the Tsyb Medical Radiological Research Centre |
(Rus)
|
|
Potapov A.L., Аgababyan T.A., Dorozhkin A.D., Pimonova I.S., Nevolskikh A.A., Ivanov S.A., Kaprin A.D.
|
| Vol 18, No 3 (2016) |
Experience in prevention of neutropenia in patients with disseminated soft tissue sarcomas receiving polychemotherapy |
(Rus)
|
|
Vladimirova L.Y., Mitashok I.S., Snezhko T.A., Samaneva N.Y., Storozhakova A.E., Kornilova I.S.
|
| Vol 24, No 3 (2022) |
Experience in the treatment of radioinduced angiosarcoma of the breast in a patient with primary multiple lesions of the breast and bladder. Case report |
(Rus)
|
|
Semenov E.V., Gasymly D.D., Zyuzyukina A.V., Zukov R.A.
|
| Vol 16, No 3 (2014) |
Experience of eribulin application in previously treated patients with metastatic or locally recurrent breast cancer under the clinical trial |
|
|
Ahmetzanov F.S., Ahmetzanova F.F.
|
| Vol 26, No 1 (2024) |
Experience of like-SJMB03 protocolin treatment of children with medulloblastomain the age group over 3 years:results of an intercenter pilot study |
(Rus)
|
|
Levashov A. ., Zagidullina S.R., Valiev T.T., Stroganova A.M., Khochenkov D.A., Grigorenko V. ., Mikhaylova E.V., Tyurina E.V., Ryzhova M.V., Horielyshev S.K., Kadyrov S. ., Polyakov V.G.
|
| Vol 25, No 2 (2023) |
Experience of surgical treatment of hemangioma of the spleen. A clinical case |
(Rus)
|
|
Chekini A.K., Novikov D.V., Avturkhanov T.M., Mkrtumyan R.A., Novikova A.O.
|
| Vol 23, No 2 (2021) |
Experience of the department of surgical treatment of bone and soft tissue tumors during COVID-19 pandemic period |
(Rus)
|
|
Bukharov A.V., Derzhavin V.A., Yadrina A.V., Erin D.A.
|
| Vol 19, No 2 (2017) |
Experience of the usage intraoperative radiation therapy after neoadjuvant systemic drug treatment and sentinel lymph node biopsy in breast cancer patients with clinical stage T2N0M0 |
(Rus)
|
|
Manikhas A.G., Grinev I.A., Oganesian A.S., Chikrizov S.I., Manikhas G.M.
|
| Vol 17, No 3 (2015) |
Experience of use of everolimus and long-acting somatostatin analogues combination in highly differentiated (G1-G2) neuroendocrine tumors |
|
|
Markovich A.A., Kuzminov A.E., Orel N.F., Odintsova A.S., Emelyanova G.S., Gorbunova V.A.
|
| Vol 15, No 2 (2013) |
Experience with Hyposalix spray treatment for xerostomia |
|
|
Afanasyev V.V., Titova O.N., Ordashev K.A., Ugurchiev Y.S.
|
| Vol 24, No 2 (2022) |
Experience with olaparib in the treatment of BRCA-associated tumors in real clinical practice. Observational study |
(Rus)
|
|
Sultanbaev A.V., Menshikov K.V., Musin S.I., Nasretdinov A.F., Fatikhova A.A., Izmailov A.A., Lipatov O.N., Ayupov R.T., Sultanbaeva N.I., Menshikova I.A., Serebrennikov G.A.
|
| Vol 25, No 3 (2023) |
Experience with the combination of tixagevimab + cilgavimab for pre-exposure prophylaxis of COVID-19 in cancer patients: A retrospective analysis |
(Rus)
|
|
Lyadova M.A., Fedorinov D.S., Kuzmina E.S., Antonova T.G., Sokolskaya V.K.
|
| Vol 17, No 5 (2015) |
Extranodal non-Hodgkin's lymphomas of the central nervous system, the testis and the pancreas |
|
|
Babicheva L.G.
|
| Vol 23, No 3 (2021) |
Extrapulmonary small cell carcinoma. Literature review |
(Rus)
|
|
Orel N.F., Poddubnaya I.V.
|
| Vol 24, No 1 (2022) |
Factors associated with the degree of 99mTc-MIBI accumulation in parathyroid glands neoplasms during planar scintigraphy and SPECT/CT in primary hyperparathyroidism |
(Rus)
|
|
Slashchuk K.Y., Degtyarev M.V., Rumyantsev P.O., Rebrova O.Y., Elfimova A.R., Selivanova L.S., Mokrysheva N.G.
|
| Vol 7, No 1 (2005) |
Faktory prognoza pri rake molochnoy zhelezy |
|
|
Bozhok A.A., Semiglazov V.F., Semiglazov V.V., Arzumanov A.S., Kletsel' A.E.
|
| Vol 8, No 3 (2006) |
Faktory prognoza v opredelenii ob\"ema operatsii pri differentsirovannom rake shchitovidnoy zhelezy |
|
|
Brzhezovskiy V.Z., Lyubaev V.L., Kochurina G.Y., Subramanian S.
|
| Vol 3, No 3 (2001) |
Farmakoekonomicheskiy analiz "stoimost'-poleznost'" kak kriteriy ekonomicheskoy obosnovannosti ispol'zovaniya byudzhetnykh sredstv v onkologii |
|
|
Poddubnaya I.V., Arkad'eva T.V., Davidenko I.S., Rozenbaum L.A.
|
| Vol 7, No 2 (2005) |
Farmorubitsin v klinicheskoy praktike |
|
|
Gorbunova V.A.
|
| Vol 13, No 2 (2011) |
Fazlodeks: novye vozmozhnostiendokrinoterapii raka molochnoy zhelezy |
|
|
Vysotskaya I.V.
|
| Vol 17, No 4 (2015) |
FDA approves ixazomib in combination with lenalidomide and dexamethasone for multiple myeloma |
|
|
- -.
|
| Vol 17, No 4 (2015) |
FDA approves Opdivo to treat advanced form of kidney cancer |
|
|
- -.
|
| Vol 16, No 4 (2014) |
Features of development of metachronous and synchronous tumors in the population of Belgorod region associated with the consequences of the Chernobyl accident |
|
|
Kovalenko B.S., Golivets T.P., Podvyaznikov S.O.
|
| Vol 22, No 3 (2020) |
Features of management of oncohematological patients in the context of the COVID-19 pandemic |
(Rus)
|
|
Poddubnaya I.V., Tumian G.S., Trofimova O.P., Babicheva L.G., Bariakh E.A., Poliakov A.S.
|
| Vol 23, No 4 (2021) |
Features of response to modern neoadjuvant chemotherapy with dual anti-HER2 blockade (trastuzumab and pertuzumab) in the patients with HER2-positive breast cancer stage II–III |
(Rus)
|
|
Morozov D.A., Kolyadina I.V., Poddubnaya I.V., Ganshina I.P., Khokhlova S.V., Kоmetova V.V., Rodionov V.V.
|
| Vol 18, No 1 (2016) |
Features of surgical treatment of patients with breast cancer receiving preoperative systemic therapy |
(Rus)
|
|
Kolyadina I.V., Poddubnaya I.V., Pavlikova O.A., Komov D.V.
|
| Vol 3, No 1 (2001) |
Febril'nye neytropenii u detey s ostrymi mieloidnymi leykozami |
|
|
Ivanova L.F., Dmitrieva N.V., Popa A.V., Bagirova N.S., Durnov L.A.
|
| Vol 9, No 3 (2007) |
Femara (letrozol) v ad\"yuvantnoy terapii raka molochnoy zhelezy |
|
|
Stenina M.B.
|
| Vol 10, No 2 (2008) |
Femara (letrozol) v sovremennoy terapii raka molochnoy zhelezy |
|
|
Perevodchikova N.I.
|
| 201 - 300 of 1319 Items |
<< < 1 2 3 4 5 6 7 8 9 10 11 12 13 14 > >> |
